Assembly Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -124.9% | – | – | – | – | – | – | – | -255.2% | – | – | |
| – | -27.6% | -61.9% | +0.0% | +3.1% | -3.0% | +3.1% | -3.0% | +0.0% | +0.0% | -18.8% | -23.1% | – | |
| – | -15.5% | -22.9% | +12.7% | -4.3% | -5.8% | -5.2% | +17.1% | +100.2% | -12.5% | -23.6% | +116.5% | – | |
| – | – | -111.0% | – | – | – | -260.6% | – | – | – | – | – | – | |
| – | -47.8% | -80.3% | +0.0% | -100.0% | – | – | – | – | -42.9% | -20.8% | -100.0% | – | |
| – | -574.8% | – | -70.4% | +379.5% | -127.3% | – | +158.0% | -1,031.3% | – | -125.4% | +1,610.9% | – | |
| – | – | -100.0% | – | -100.0% | – | -88.7% | -81.4% | +48,060.2% | -99.7% | -67.3% | +72,876.5% | – | |
| – | -235.4% | – | – | +1,913.9% | +7.0% | -250.9% | – | -348.2% | – | -176.1% | – | – | |
| – | – | -125.0% | – | – | – | – | – | – | – | -255.6% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.